Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

This study has been terminated.

( See Detailed Description )

Study NCT00031278 Information provided by Pfizer

First Received: February 28, 2002 Last Updated: December 15, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2003
Primary Completion Date:	June 2003 (Final data collection date for primary outcome measure)